REVA to Present Fantom 24-Month Data at TCT 2017
October 23, 2017 19:39 ET
|
REVA Medical Inc
SAN DIEGO, Oct. 23, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce the Company’s scheduled presentations during the upcoming Transcatheter...
REVA Announces Commercial Expansion and the First Implant of the Fantom Bioresorbable Scaffold in Switzerland
October 16, 2017 06:00 ET
|
REVA Medical Inc
SAN DIEGO, Oct. 16, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) announced today the commercial expansion of its bioresorbable scaffold (“BRS”), Fantom®, with the...
REVA Announces Ray Larkin Jr. as Chairman of the Board of Directors
September 20, 2017 07:00 ET
|
REVA Medical Inc
SAN DIEGO, Sept. 20, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) announced today that its Board of Directors has appointed Ray Larkin Jr., a current member of the...
Notice of REVA Medical Briefing Call
August 07, 2017 12:53 ET
|
REVA Medical Inc
SAN DIEGO, Aug. 07, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) will hold a briefing call on Thursday, August 10, 2017 at 4:00 p.m. PDT (which is 9:00 a.m. AEST...
Boston Scientific’s Distribution Option Lapses
August 03, 2017 21:06 ET
|
REVA Medical Inc
SAN DIEGO, Aug. 03, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) announces the expiration of Boston Scientific Corporation’s (“BSC”) exclusive right to negotiate...
REVA Medical Announces Organizational Changes
July 13, 2017 19:24 ET
|
REVA Medical Inc
SAN DIEGO, July 13, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA), as part of its transition to commercial operations, today announced the hiring of a new chief financial officer, a vice...
REVA Financing Completed
June 19, 2017 19:10 ET
|
REVA Medical Inc
SAN DIEGO, June 19, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) announces that it has closed the second tranche and, therefore, has completed the financing...
REVA Symposium Showcases Clinical Data
May 17, 2017 20:59 ET
|
REVA Medical Inc
Company discusses positive long-term data, expanded clinical trials, and plans for growth SAN DIEGO, May 17, 2017 (GLOBE NEWSWIRE) -- Today at the Paris Course on Revascularization (“EuroPCR”),...
REVA Announces Positive 12-Month Clinical Results
May 16, 2017 15:34 ET
|
REVA Medical Inc
SAN DIEGO, May 16, 2017 (GLOBE NEWSWIRE) -- At the Paris Course on Revascularization (“EuroPCR”) being held this week in Paris, France, REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”)...
REVA Arranges Convertible Note Financing
April 24, 2017 20:20 ET
|
REVA Medical Inc
SAN DIEGO, April 24, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that it has entered into an agreement with several institutional and one...